These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1771528)

  • 1. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
    Turowski A; Schmidt H; Sternitzky R; Brehme S; Keysser G; Hiebsch G; Hiebsch U
    Vasa Suppl; 1991; 32():338-41. PubMed ID: 1771528
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
    Weidinger P; Bilek M; Tekusch A
    Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemorheologic risk profile in peripheral arterial occlusive disease, diabetic angiopathy and essential arterial hypertension].
    Sternitzky R; Wiederhold KF; Hänsgen K; Jäger H; Turowski A; Voigt H
    Vasa Suppl; 1991; 32():325-31. PubMed ID: 1771526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
    Pöhlmann G; Braumann A; Grohmann G
    Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of hemodilution on systemic and capillary hematocrit].
    Jung F; Koscielny J; Mrowietz C; Wolf S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1990 Oct; 17(5):268-75. PubMed ID: 1705247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].
    Sternitzky R; Hänsgen K; Podhaisky H
    Z Gesamte Inn Med; 1991 Nov; 46(16):610-4. PubMed ID: 1792802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
    Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical aspects of hemorheology in the aged].
    Staedt U; Heene DL
    Internist (Berl); 1991 Aug; 32(8):447-52. PubMed ID: 1938264
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
    Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodilution in cerebral ischemia. Farewell to a common treatment concept].
    Back T; von Kummer R
    Dtsch Med Wochenschr; 1989 Mar; 114(9):350-4. PubMed ID: 2646096
    [No Abstract]   [Full Text] [Related]  

  • 11. [The principle of hemodilution].
    Messmer K; Frey L
    Chirurg; 1991 Nov; 62(11):769-74. PubMed ID: 1769256
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic infusions of middle molecular weight hydroxyethyl starch (10%, 200,000/0.62) in healthy probands].
    Scheffler P; Jung F; Mrowietz C; Waldhausen P; Leipnitz G; Häuser B
    Infusionsther Klin Ernahr; 1987 Oct; 14(5):233-8. PubMed ID: 2445681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isovolemic hemodilution in cerebral ischemic attack: clinical and hemorheological evaluation].
    Porro F; Curti L; Figini G; Pastori M
    Ric Clin Lab; 1989; 19 Suppl 1():113-6. PubMed ID: 2629068
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemorheology in patients with Raynaud's phenomenon--diagnosis and therapy with plasmapheresis].
    Sakriss U; Toussaint C; Turowski A; Schmidt H; Nieter B
    Vasa Suppl; 1991; 32():347-9. PubMed ID: 1771530
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
    Höffkes HG; Saeger-Lorenz K; Ehrly AM
    Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-thixotropic therapy in arterial occlusive disorders: What is the effectiveness of "rheological procedures" in the presence of persisting obliterations?].
    Schmid-Schönbein H
    Wien Med Wochenschr; 1985 Aug; 135(15-16):368-79. PubMed ID: 4060740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Induced hemodilution as a new concept in the therapy of peripheral circulatory disorders].
    Rieger H
    Internist (Berl); 1982 Jul; 23(7):375-82. PubMed ID: 7049999
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemorheology and hemodilution].
    Stoltz JF
    Ann Fr Anesth Reanim; 1986; 5(3):193-203. PubMed ID: 3535578
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.